BR0315335A - Processo para a preparação de (s,s)-cis-2-benzidril-3-benzilaminoquinuclina - Google Patents
Processo para a preparação de (s,s)-cis-2-benzidril-3-benzilaminoquinuclinaInfo
- Publication number
- BR0315335A BR0315335A BR0315335-5A BR0315335A BR0315335A BR 0315335 A BR0315335 A BR 0315335A BR 0315335 A BR0315335 A BR 0315335A BR 0315335 A BR0315335 A BR 0315335A
- Authority
- BR
- Brazil
- Prior art keywords
- acid
- organic
- cis
- chiral
- isomer
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 150000001735 carboxylic acids Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000002466 imines Chemical class 0.000 abstract 2
- 150000002576 ketones Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 239000003960 organic solvent Substances 0.000 abstract 2
- 239000002841 Lewis acid Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000007517 lewis acids Chemical class 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41905102P | 2002-10-16 | 2002-10-16 | |
| PCT/US2003/032275 WO2004035575A1 (en) | 2002-10-16 | 2003-10-10 | Process for the preparation of (s,s)-cis-2-benzhydryl-3-benzylaminoquinuclidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0315335A true BR0315335A (pt) | 2005-08-16 |
Family
ID=32108014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0315335-5A BR0315335A (pt) | 2002-10-16 | 2003-10-10 | Processo para a preparação de (s,s)-cis-2-benzidril-3-benzilaminoquinuclina |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6861526B2 (enExample) |
| EP (1) | EP1551833A4 (enExample) |
| JP (1) | JP2006506368A (enExample) |
| KR (1) | KR100739901B1 (enExample) |
| CN (1) | CN100418964C (enExample) |
| AP (1) | AP2005003288A0 (enExample) |
| AR (1) | AR041587A1 (enExample) |
| AU (1) | AU2003277353B2 (enExample) |
| BR (1) | BR0315335A (enExample) |
| CA (1) | CA2500635A1 (enExample) |
| EA (1) | EA008192B1 (enExample) |
| HR (1) | HRP20050328A2 (enExample) |
| IS (1) | IS7755A (enExample) |
| MX (1) | MXPA05004058A (enExample) |
| PA (1) | PA8586601A1 (enExample) |
| PE (1) | PE20040777A1 (enExample) |
| PL (1) | PL376218A1 (enExample) |
| TN (1) | TNSN05111A1 (enExample) |
| UY (1) | UY28024A1 (enExample) |
| WO (1) | WO2004035575A1 (enExample) |
| ZA (1) | ZA200502411B (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| HUE034099T2 (en) * | 2004-01-30 | 2018-01-29 | Zoetis Services Llc | Antimicrobial preservatives for the delivery of multidose formulations using beta-cyclodextrins for liquid dosage forms |
| DK1713801T3 (da) * | 2004-02-02 | 2008-03-17 | Pfizer Prod Inc | Fremgangsmåde til fremstilling af 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amin |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| BRPI0711558A2 (pt) | 2006-05-04 | 2011-11-08 | Boeringer Ingelheim Internat Gmbh | polimorfos |
| PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| BRPI0916997A2 (pt) | 2008-08-06 | 2020-12-15 | Boehringer Ingelheim International Gmbh | Inibidor de dpp-4 e seu uso |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| EP2382216A1 (en) | 2008-12-23 | 2011-11-02 | Boehringer Ingelheim International GmbH | Salt forms of organic compound |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| EA034869B1 (ru) | 2009-11-27 | 2020-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин |
| MX341025B (es) | 2010-05-05 | 2016-08-04 | Boehringer Ingelheim Int Gmbh * | Terapia de combinacion. |
| PH12012502524A1 (en) | 2010-06-24 | 2014-02-10 | Boehringer Ingelheim Int | Diabetes therapy |
| US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| EP3517539B1 (en) | 2011-07-15 | 2022-12-14 | Boehringer Ingelheim International GmbH | Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| US20130303554A1 (en) | 2012-05-14 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Use of a dpp-4 inhibitor in sirs and/or sepsis |
| JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体 |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
| CN109310697A (zh) | 2016-06-10 | 2019-02-05 | 勃林格殷格翰国际有限公司 | 利格列汀和二甲双胍的组合 |
| CN108341812A (zh) * | 2017-01-23 | 2018-07-31 | 科贝源(北京)生物医药科技有限公司 | 一种含奎宁环化合物的制备方法 |
| CN108341811A (zh) * | 2017-01-23 | 2018-07-31 | 科贝源(北京)生物医药科技有限公司 | 马罗皮坦杂质的制备方法 |
| CN106977512B (zh) * | 2017-05-04 | 2019-01-01 | 海门慧聚药业有限公司 | 制备马罗匹坦游离碱的方法 |
| WO2025172911A1 (en) * | 2024-02-16 | 2025-08-21 | Teadus Pharmaceuticals Pvt. Ltd | A process for the preparation of (2s,3s)-2-benzhydryl- n-(5-tert-butyl-2-methoxybenzyl) quinuclidin-3-amine and pharmaceutically acceptable salts thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3560510A (en) * | 1969-03-05 | 1971-02-02 | Aldrich Chem Co Inc | 2-benzhydrylquinuclidines |
| US4680283A (en) | 1984-09-26 | 1987-07-14 | Merck & Co., Inc. | Analogs of substance P and eledoisin |
| MX18467A (es) | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
| US5138060A (en) | 1991-01-03 | 1992-08-11 | Pfizer Inc. | Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
| RU2092486C1 (ru) * | 1991-05-22 | 1997-10-10 | Пфайзер Инк. | Замещенные 3-аминохинуклидины |
| BR9206073A (pt) | 1991-05-31 | 1994-12-06 | Pfizer | Derivados de quinuclidina |
| JP2909214B2 (ja) | 1992-08-19 | 1999-06-23 | フアイザー・インコーポレイテツド | 置換ベンジルアミノ窒素含有非芳香族複素環化合物 |
| US5604241A (en) * | 1992-10-21 | 1997-02-18 | Pfizer Inc. | Substituted benzylaminoquinuclidines as substance P antagonists |
| JP2656699B2 (ja) | 1992-10-21 | 1997-09-24 | ファイザー製薬株式会社 | 置換ベンジルアミノキヌクリジン |
| JP2656700B2 (ja) | 1992-10-28 | 1997-09-24 | ファイザー製薬株式会社 | 置換キヌクリジン誘導体 |
| NZ254604A (en) | 1992-11-12 | 1997-06-24 | Pfizer | Quinuclidine derivative and pharmaceutical compositions thereof |
| IL109646A0 (en) | 1993-05-19 | 1994-08-26 | Pfizer | Heteroatom substituted alkyl benzylamino-quinuclidines |
| PE8798A1 (es) * | 1995-07-17 | 1998-03-02 | Pfizer | Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil] |
| MX9706944A (es) | 1996-09-12 | 1998-08-30 | Pfizer | Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p. |
-
2003
- 2003-10-06 US US10/679,961 patent/US6861526B2/en not_active Expired - Fee Related
- 2003-10-10 CA CA002500635A patent/CA2500635A1/en not_active Abandoned
- 2003-10-10 BR BR0315335-5A patent/BR0315335A/pt not_active IP Right Cessation
- 2003-10-10 AU AU2003277353A patent/AU2003277353B2/en not_active Ceased
- 2003-10-10 EA EA200500650A patent/EA008192B1/ru not_active IP Right Cessation
- 2003-10-10 PL PL03376218A patent/PL376218A1/xx not_active Application Discontinuation
- 2003-10-10 EP EP03808986A patent/EP1551833A4/en not_active Withdrawn
- 2003-10-10 JP JP2004544849A patent/JP2006506368A/ja active Pending
- 2003-10-10 AP AP2005003288A patent/AP2005003288A0/xx unknown
- 2003-10-10 CN CNB200380101563XA patent/CN100418964C/zh not_active Expired - Fee Related
- 2003-10-10 WO PCT/US2003/032275 patent/WO2004035575A1/en not_active Ceased
- 2003-10-10 HR HR20050328A patent/HRP20050328A2/xx not_active Application Discontinuation
- 2003-10-10 MX MXPA05004058A patent/MXPA05004058A/es active IP Right Grant
- 2003-10-10 KR KR1020057006471A patent/KR100739901B1/ko not_active Expired - Fee Related
- 2003-10-10 AR ARP030103709A patent/AR041587A1/es unknown
- 2003-10-14 PE PE2003001050A patent/PE20040777A1/es not_active Application Discontinuation
- 2003-10-15 UY UY28024A patent/UY28024A1/es not_active Application Discontinuation
- 2003-10-16 PA PA20038586601A patent/PA8586601A1/es unknown
-
2004
- 2004-10-27 US US10/974,447 patent/US20050085641A1/en not_active Abandoned
-
2005
- 2005-03-17 IS IS7755A patent/IS7755A/is unknown
- 2005-03-23 ZA ZA200502411A patent/ZA200502411B/en unknown
- 2005-04-15 TN TNP2005000111A patent/TNSN05111A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006506368A (ja) | 2006-02-23 |
| EP1551833A4 (en) | 2010-06-02 |
| US20050085641A1 (en) | 2005-04-21 |
| PA8586601A1 (es) | 2005-02-04 |
| MXPA05004058A (es) | 2005-06-08 |
| EP1551833A1 (en) | 2005-07-13 |
| US6861526B2 (en) | 2005-03-01 |
| CN1705664A (zh) | 2005-12-07 |
| UY28024A1 (es) | 2004-05-31 |
| TNSN05111A1 (en) | 2007-05-14 |
| HK1078087A1 (en) | 2006-03-03 |
| KR20050083764A (ko) | 2005-08-26 |
| WO2004035575A8 (en) | 2005-05-12 |
| EA008192B1 (ru) | 2007-04-27 |
| PL376218A1 (en) | 2005-12-27 |
| CN100418964C (zh) | 2008-09-17 |
| WO2004035575A1 (en) | 2004-04-29 |
| AR041587A1 (es) | 2005-05-26 |
| AP2005003288A0 (en) | 2005-06-30 |
| PE20040777A1 (es) | 2004-11-20 |
| EA200500650A1 (ru) | 2005-10-27 |
| CA2500635A1 (en) | 2004-04-29 |
| US20040116704A1 (en) | 2004-06-17 |
| IS7755A (is) | 2005-03-17 |
| ZA200502411B (en) | 2006-05-31 |
| HRP20050328A2 (en) | 2005-06-30 |
| AU2003277353A1 (en) | 2004-05-04 |
| KR100739901B1 (ko) | 2007-07-13 |
| AU2003277353B2 (en) | 2007-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR041587A1 (es) | Proceso para la preparacion de (s,s)-cis-2-benzhidril-3- benzilaminoquinuclidina | |
| BR0316902A (pt) | Processos para preparar (+)duloxetina e hidrocloreto de (+)duloxetina, sal de ácido quiral e (+)duloxetina, di-p-toluil tartarato de (+)duloxetina, (+)duloxetina e composição farmacêutica | |
| BR9815464A (pt) | Polìmero, processo de preparação de polìmeros, utilização de um polìmero, composição, associação de pelo menos um polìmero com pelo menos um composto e composição cosmética | |
| DE60315709D1 (de) | Festphasenherstellung von 18f-markierten aminosäuren | |
| BR0213505A (pt) | Método de resolução de racemato de amlodipina | |
| BR0301667A (pt) | Processo para a preparação de polìmeros em emulsão com pureza elevada | |
| BRPI0409038A (pt) | processos para preparação de um produto de reação, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante | |
| BR9915868A (pt) | Processo para a decomposição de tramadol | |
| DE602006008962D1 (de) | Verfahren zur herstellung von valsartan | |
| BR0205172A (pt) | Processo para a sìntese de esfingosina | |
| BR0210512A (pt) | Processo de decomposição papa o ácido (r)-(-)-2-hidroxi-2-(2-clorofenil) acético | |
| BRPI0415347A (pt) | processo para a produção de bicalutamida e método para a purificação de intermediário da mesma | |
| BR0110782A (pt) | Processo para preparação de compostos de bifenila | |
| BR0115262A (pt) | Derivados de amina opticamente ativos e processo de preparação destes | |
| BRPI0411558A (pt) | processo para a preparação de um composto, composto, e, processo para produzir o enanciÈmero (2s) do composto | |
| BRPI0317781B8 (pt) | derivado de acilbenzilamina e processos para produção de derivado de benzilamina e de derivado de carbamato | |
| BR0010907A (pt) | Processo para a produção de poliamidas, e, poliamida | |
| IL161436A0 (en) | A process for the optical resolution of a precursor of sclareolide | |
| BRPI0409737A (pt) | tratamento de pigmentos de alto desempenho, composição do mesmo; sal de fórmula; processo de sintetização e método de obtenção | |
| WO2005056539A3 (en) | A process for the resolution of nefopam | |
| EP1489066A4 (en) | PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE CARBOXYLIC ACID | |
| BRPI0409495A (pt) | processo para hidrogenar um composto monoolefinicamente insaturado | |
| BRPI0409644A (pt) | processo para a preparação de nicotinaldeìdos | |
| BRPI0508260A (pt) | sal de metal alcalino terroso ou um sal de amina orgánico de um composto, composto, processo para a produção de um sal de metal alcalino terroso de um composto, cristal, medicamento, agente para a regressão, inibição da progressão ou estabilização de uma lesão arteriosclerótica ou aterosclerótica, uso do composto | |
| BRPI0411409A (pt) | processo para a preparação de derivados de ácido propanóico e processo para a preparação de um composto tendo a fórmula (1a) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A E 8A ANUIDADES. |